172 related articles for article (PubMed ID: 36096078)
41. Polyneuropathy in paraproteinaemia.
Meier C
J Neurol; 1985; 232(4):204-14. PubMed ID: 2995596
[TBL] [Abstract][Full Text] [Related]
42. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
[TBL] [Abstract][Full Text] [Related]
43. Monoclonal gammopathy of cutaneous significance.
Hussain K; Mehta D; Patel P; Roberts N
Clin Exp Dermatol; 2022 Apr; 47(4):778. PubMed ID: 34905231
[No Abstract] [Full Text] [Related]
44. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
López Gómez JM; Sacristán Enciso B; Fernández-Cavada Pollo MJ; Bueno García V; Gómez Vera S
Semergen; 2021 Oct; 47(7):441-447. PubMed ID: 34479794
[TBL] [Abstract][Full Text] [Related]
45. Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause.
Kastritis E; Kanellias N; Theodorakakou F; Psimenou E; Gakiopoulou C; Marinaki S; Roussou M; Gavriatopoulou M; Migkou M; Fotiou D; Eleutherakis-Papaiakovou E; Malandrakis P; Terpos E; Dimopoulos MA
Leuk Lymphoma; 2020 Dec; 61(13):3247-3250. PubMed ID: 32716220
[No Abstract] [Full Text] [Related]
46. A case of type I cryoglobulinaemia vasculitis associated with monoclonal gammopathy of undetermined significance exacerbated by a progression to multiple myeloma.
Hng M; Liam CC; Chew TK
QJM; 2022 Aug; 115(8):551-552. PubMed ID: 35482531
[No Abstract] [Full Text] [Related]
47. Monoclonal gammopathy of thrombotic/thrombocytopenic significance.
Kanack AJ; Schaefer JK; Sridharan M; Splinter NP; Kohlhagen MC; Singh B; De Lorenzo SB; Mauch EE; Hussein MA; Shaikh M; Kumar S; Wen R; Wang D; Murray D; Padmanabhan A
Blood; 2023 Apr; 141(14):1772-1776. PubMed ID: 36626584
[No Abstract] [Full Text] [Related]
48. Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.
Kyle RA; Rajkumar SV
JAMA Oncol; 2015 May; 1(2):174-5. PubMed ID: 26181018
[No Abstract] [Full Text] [Related]
49. [Thoracic changes in multiple myeloma and monoclonal gammopathy].
Załeska J; Figura-Chojak E; Lesiak B; Wasowska H
Pneumonol Pol; 1985; 53(11-12):546-53. PubMed ID: 3834409
[No Abstract] [Full Text] [Related]
50. [Pitfalls of monoclonal gammopathy].
Meuleman N
Rev Med Brux; 2013 Sep; 34(4):335-8. PubMed ID: 24195249
[TBL] [Abstract][Full Text] [Related]
51. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA
Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
[TBL] [Abstract][Full Text] [Related]
52. [Polyneuropathy associated with monoclonal serum proteins and plasma cell dyscrasias].
Smith T
Ugeskr Laeger; 1986 Oct; 148(42):2667-9. PubMed ID: 3024374
[No Abstract] [Full Text] [Related]
53. Diffuse plane xanthoma developing in association with prior monoclonal gammopathy.
Falk L; Dyall-Smith D; Stolz W; Coras-Stepanek B
BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30765451
[No Abstract] [Full Text] [Related]
54. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
[TBL] [Abstract][Full Text] [Related]
55. Co-occurrence of monoclonal gammopathy and myelodysplasia: a retrospective study of fourteen cases.
Yoshida Y; Oguma S; Ohno H; Nakabo Y; Katsurada T; Kawahara M; Kawabata H
Int J Hematol; 2014 Jun; 99(6):721-5. PubMed ID: 24687918
[TBL] [Abstract][Full Text] [Related]
56. The psychosocial impact of the COVID-19 pandemic on patients with monoclonal gammopathy of undermined significance, smouldering and active myeloma: findings from an international survey.
Quinn SJ; Anderson LA; Lohfeld L; McShane CM
Br J Haematol; 2021 Jul; 194(2):294-297. PubMed ID: 33763875
[No Abstract] [Full Text] [Related]
57. Primary hyperparathyroidism and monoclonal gammopathy.
Rao DS; Antonelli R; Kane KR; Kuhn JE; Hetnal C
Henry Ford Hosp Med J; 1991; 39(1):41-4. PubMed ID: 1856101
[TBL] [Abstract][Full Text] [Related]
58. Paraproteinemic keratopathy in monoclonal gammopathy of undetermined significance treated with primary keratoprosthesis: Case report, histopathologic findings, and world literature review.
Chiang HH; Wieland RS; Rogers TS; Gibson PC; Atweh G; McCormick G
Medicine (Baltimore); 2017 Dec; 96(50):e8649. PubMed ID: 29390260
[TBL] [Abstract][Full Text] [Related]
59. Light-chain MGUS: implications for clinical practice.
van Rhee F
Lancet; 2010 May; 375(9727):1670-1. PubMed ID: 20472153
[No Abstract] [Full Text] [Related]
60. Crystal-storing histiocytosis associated with monoclonal kappa light chain gammopathy.
Lesesve JF; Thomas B
Int J Lab Hematol; 2022 Dec; 44(6):978-979. PubMed ID: 35451182
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
